Sanofi Starts Bidding Process to Sell Consumer Health Division, Bloomberg Reports
-- Sanofi is seeking buyers for its consumer health arm as it simultaneously plans to potentially list the unit, Bloomberg reported, citing unnamed sources.
-- The French pharmaceutical giant set a mid-July deadline for first-round bids, Bloomberg reported. Private equity firms Advent and France's PAI Partners are seen as frontrunners, while Blackstone, Clayton Dubilier & Rice, CVC Capital Partners and TPG are considering bids for the company, according to Bloomberg.
-- Sanofi said it is reviewing potential separation scenarios, with a transaction at the earliest in the last quarter of 2024. "We are keeping all options open to maximize value creation for all our stakeholders," the company said after a request for comment from Dow Jones. The company first set out plans to separate the division in October.
Full story: https://bit.ly/4cCoqbo
Write to Helena Smolak at helena.smolak@wsj.com
(END) Dow Jones Newswires
June 26, 2024 03:15 ET (07:15 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations